Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Seagen (SGEN) stocks

Learn how to easily invest in Seagen stocks.

Seagen (SGEN) is a leading biotechnology business based in the US. It opened the day at $148.42 after a previous close of $148.96. During the day the price has varied from a low of $146.75 to a high of $149.63. The latest price was $148.5 (25 minute delay). Seagen is listed on the NASDAQ and employs 3,256 staff. All prices are listed in US Dollars.

How to buy Seagen stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SGEN. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners

Promoted

National Bank Direct Brokerage


  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge


  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers


  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Seagen stock price (NASDAQ:SGEN)

Use our graph to track the performance of SGEN stocks over time.

Seagen shares at a glance

Information last updated 2021-07-09.
Open$148.42
High$149.63
Low$146.75
Close$148.50
Previous close$148.96
Change $-0.46
Change % -0.3088%
Volume 1,028,384
Information last updated 2023-05-27.
52-week range$116.08 - $207.17
50-day moving average $200.30
200-day moving average $156.92
Wall St. target price$222.64
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.46

Buy Seagen stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
★★★★★
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
★★★★★
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95–$6.95
$0 if conditions met, or $100
N/A
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
$0
N/A
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Questrade
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
$0
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
★★★★★
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
loading

Is it a good time to buy Seagen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Seagen price performance over time

Historical closes compared with the close of $148.5 from 2023-05-26

1 week (2023-05-23) -24.42%
1 month (2023-04-28) -25.75%
3 months (2023-03-02) -16.89%
6 months (2022-11-30) 22.33%
1 year (2022-05-27) 5.03%
2 years (2021-05-28) -4.41%
3 years (2020-05-29) 157.21
5 years (2018-05-30) 161.54%

Is Seagen stock undervalued or overvalued?

Valuing Seagen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Seagen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Seagen financials

Revenue TTM $2.1 billion
Gross profit TTM $208 million
Return on assets TTM -11.6%
Return on equity TTM -22.67%
Profit margin -31.55%
Book value $14.54
Market capitalisation $36.3 billion

TTM: trailing 12 months

Seagen's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Seagen.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Seagen's total ESG risk score

Total ESG risk: 29.88

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Seagen's overall score of 29.88 (as at 01/01/2019) is nothing to write home about – landing it in it in the 56th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Seagen is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Seagen's environmental score

Environmental score: 1.18/100

Seagen's environmental score of 1.18 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Seagen's social score

Social score: 23.34/100

Seagen's social score of 23.34 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Seagen is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Seagen's governance score

Governance score: 10.36/100

Seagen's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Seagen is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Seagen share dividends

We're not expecting Seagen to pay a dividend over the next 12 months.

Seagen share price volatility

Over the last 12 months, Seagen's shares have ranged in value from as little as $116.08 up to $207.17. A popular way to gauge a stock's volatility is its "beta".

SGEN.US volatility(beta: 0.53)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Seagen's is 0.532. This would suggest that Seagen's shares are less volatile than average (for this exchange).

Seagen overview

Seagen Inc. , a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc. ; Genmab A/S; Merck; and RemeGen, Co. Ltd.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site